Janssen had recently acquired the rights to manufacture and distribute Zytiga, and the team saw an opportunity to improve the way the active pharmaceutical ingredient was produced, to decrease its environmental impact, using the Earthwards process to guide the improvement.

FORBES: Diving Deeper: How High Should We Set the Bar?